Our Interactive calculator demonstrates the healthcare and work-loss costs to your organization due to opiod abuse

$62,453

Annual Healthcare Cost To Employer (Abuser)

$32,625

Excess Healthcare Cost of an Abuser vs Non-Abuser

$11,583

Annual In-direct Work-Loss Costs

Source

**Calculations are based upon the national average of abusers per 10,000 employees. Update Source: Analysis Group, Inc, (pg. 441)

Start Saving Today!

Call Us to Learn More (888) 603-8181

Personalized Medication

Pharmacogenetics

How We Help Self-Insured Employers and Unions

Opiate Epidemic In The U.S.

The latest from the Newsroom

Experience the advantage of excellent service, solutions, partnership, integrity and innovation with a leading multi-specialty health care company like Advanced Therapeutics. 

Reno Considering Opioid Lawsuit Despite AG’s Wishes

The suit would seek damages from drug manufacturers as part of an effort to recoup some of the costs the city has faced that are associated with opioid abuse.

However, in a letter sent to Reno Mayor Hillary Schieve last week, Nevada Attorney General Adam Laxalt urged the city to halt the possible lawsuit out of fear that it could derail Nevada’s role in a multi-state investigation of deceptive trade practices by the drug manufacturers.

But Schieve says the city has the right to pursue any course of action to help fight opioid addiction in Reno.

“We see it every day,” says Schieve. “Mayors are not about party, we’re about people. I see the devastation that’s happening in our city first hand; the lives that are lost and the stress that it’s putting on our public safety, our fire, our police, our EMS. It’s critical.”

According to a report by the non-profit Trust for America’s Health, Nevada has been ranked 4th in the nation for drug overdose deaths.

Article Link

Read More

Cardinal Health announced program to address opioid crisis

As Cardinal Health continues to face lawsuits over its alleged role in stoking the national opioid crisis, the company on Thursday is scheduled to announce a sweeping program in Appalachia aimed at combating drug abuse.

Its Opioid Action Program, in cooperation with local partners in Ohio, Kentucky, Tennessee and West Virginia, is being called a pilot program that could be expanded over time.

The Dublin-based company, one of the nation’s three dominant distributors of drugs made by other companies, is targeting an initial $10 million investment in the program through June 2018, the end of Cardinal’s fiscal year. The key steps Cardinal will take include:

‒ Buy and distribute, free of charge, approximately 80,000 doses of Narcan, also known by its generic name naloxone HC, to first responders and law enforcement officials in the target areas.

‒ Increase its existing support for drug-disposal and education programs, building on the Cardinal Health Foundation’s Generation Rx program in partnership with the Ohio State University College of Pharmacy.

Article Link

Read More